Type 2 Diabetes Significantly Increases Risk of MASH Progression to Cirrhosis, New Target RWE Study Reveals
New research from Target RWE presented at EASL 2025 demonstrates that individuals with Type 2 diabetes have significantly higher risk of progressing from MASH to cirrhosis, independent of age, sex, or fibrosis risk group.
Target RWE Showcases Groundbreaking Liver Disease Research at EASL Congress 2025
Target RWE presented significant findings on MASH and HCC at EASL Congress 2025, revealing that Type 2 diabetes substantially increases the risk of progression to MASH-related cirrhosis.
© Copyright 2025. All Rights Reserved by MedPath